Coronary heart disease attack rate, incidence and mortality 1975-1994 in Göteborg, Sweden

L Wilhelmsen1, A Rosengren, S Johansson

  • 1Department of Medicine, Ostra University Hospital, Göteborg University, Sweden.

Insights

Coronary heart disease incidence and mortality are decreasing in Sweden for individuals under 65. Improved hospital treatments contributed to lower short-term mortality, but primary prevention remains crucial.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary heart disease (CHD) poses a significant public health challenge.
  • Understanding trends in myocardial infarction (MI) and CHD mortality is vital for effective prevention and treatment strategies.

Purpose of the Study:

  • To investigate trends in MI attack rates, incidence, and CHD mortality in individuals aged 64 and below in Sweden between 1975 and 1994.
  • To analyze the impact of changing treatment protocols on patient outcomes.

Main Methods:

  • Utilized data from the Göteborg myocardial infarction register.
  • Analyzed trends in attack rate, incidence, and mortality for defined age groups (35-64 years) over a 20-year period.
  • Defined MI using consistent criteria throughout the study.

Main Results:

  • MI attack rates and incidence were significantly higher in men than women.
  • Both attack rate and incidence of MI decreased annually (2.1-3.9%) across most age groups.
  • 28-day fatality rates showed a declining trend, particularly in older men, with improved in-hospital treatments (beta-blockers, thrombolytics).
  • CHD mortality decreased by 2.0-6.8% per year, though most deaths occurred outside hospitals.
  • Use of coronary surgery and angioplasty increased substantially by 1994.

Conclusions:

  • CHD incidence and mortality are declining in individuals under 65 in Sweden.
  • Improved in-hospital MI management significantly reduced short-term mortality.
  • The majority of CHD deaths occur outside hospitals, emphasizing the continued importance of primary prevention efforts.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...